MedPath

Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma

Not yet recruiting
Conditions
Bleomycin Adverse Reaction
Interventions
Device: Diode laser
Registration Number
NCT06510829
Lead Sponsor
Assiut University
Brief Summary

Assessment of the Effectiveness of Bleomycin Intralesional Injection and Diode Laser on Management of Infantile Hemangioma., with regard to :

* Clinically based on Change in the Size and Color of Hemangioma.

* Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology .

* Comparison of Complications associated with Bleomycin and Diode Laser.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age between 3 Months and 1 Year old.
  • Non Complicated Infantile Hemangioma
Exclusion Criteria
  • Younger than 3 Months or older than 1 Year.
  • Complicated Infantile Hemangioma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group bDiode laserGroup will be treated with application of diode laser
Primary Outcome Measures
NameTimeMethod
Effect of diode laser on hemangioma3 years
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath